Royal Bank of Canada’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-173,945
Closed -$51K 7229
2023
Q3
$51K Buy
173,945
+55,185
+46% +$16.2K ﹤0.01% 5293
2023
Q2
$57K Sell
118,760
-4,368
-4% -$2.1K ﹤0.01% 5270
2023
Q1
$78K Buy
123,128
+4,878
+4% +$3.09K ﹤0.01% 4986
2022
Q4
$54K Buy
118,250
+112,501
+1,957% +$51.4K ﹤0.01% 5365
2022
Q3
$5K Buy
5,749
+424
+8% +$369 ﹤0.01% 6276
2022
Q2
$6K Sell
5,325
-6,506
-55% -$7.33K ﹤0.01% 6143
2022
Q1
$15K Buy
11,831
+978
+9% +$1.24K ﹤0.01% 6290
2021
Q4
$18K Sell
10,853
-37,436
-78% -$62.1K ﹤0.01% 6318
2021
Q3
$134K Buy
48,289
+32,312
+202% +$89.7K ﹤0.01% 4991
2021
Q2
$48K Buy
15,977
+4,549
+40% +$13.7K ﹤0.01% 5585
2021
Q1
$47K Sell
11,428
-11,999
-51% -$49.3K ﹤0.01% 5432
2020
Q4
$110K Buy
+23,427
New +$110K ﹤0.01% 4752